SAR341402

DRUG2 trials

Sponsors

Sanofi

Conditions

Type 1 Diabetes

Phase 1

A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus

CompletedNCT03202875

SanofiType 1 Diabetes

Start: 2012-11-14End: 2012-12-28Updated: 2022-04-25

Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus

CompletedNCT03916601

SanofiType 1 Diabetes

Start: 2017-12-13End: 2018-03-22Updated: 2022-04-25

Related Papers

Single-Dose Euglycemic Clamp Study Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and US- and EU-Approved Versions of Insulin Aspart in Subjects with Type 1 Diabetes

Diabetes Technology & Therapeutics2019-12-1118 citations